- Home
- TXMD vs EPWK Comparison
TXMD vs EPWK Comparison
Compare TXMD & EPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- EPWK
- Stock Information
- Founded
- TXMD 2008
- EPWK 2011
- Country
- TXMD United States
- EPWK China
- Employees
- TXMD N/A
- EPWK N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- EPWK
- Sector
- TXMD Health Care
- EPWK
- Exchange
- TXMD Nasdaq
- EPWK Nasdaq
- Market Cap
- TXMD 13.5M
- EPWK 11.0M
- IPO Year
- TXMD N/A
- EPWK 2025
- Fundamental
- Price
- TXMD $1.14
- EPWK $0.59
- Analyst Decision
- TXMD
- EPWK
- Analyst Count
- TXMD 0
- EPWK 0
- Target Price
- TXMD N/A
- EPWK N/A
- AVG Volume (30 Days)
- TXMD 30.4K
- EPWK 951.9K
- Earning Date
- TXMD 07-30-2025
- EPWK 05-27-2025
- Dividend Yield
- TXMD N/A
- EPWK N/A
- EPS Growth
- TXMD N/A
- EPWK N/A
- EPS
- TXMD N/A
- EPWK N/A
- Revenue
- TXMD $1,841,000.00
- EPWK $20,164,008.00
- Revenue This Year
- TXMD $427.09
- EPWK N/A
- Revenue Next Year
- TXMD N/A
- EPWK N/A
- P/E Ratio
- TXMD N/A
- EPWK N/A
- Revenue Growth
- TXMD 53.55
- EPWK 10.25
- 52 Week Low
- TXMD $0.70
- EPWK $0.41
- 52 Week High
- TXMD $2.44
- EPWK $26.00
- Technical
- Relative Strength Index (RSI)
- TXMD 43.84
- EPWK N/A
- Support Level
- TXMD $1.07
- EPWK N/A
- Resistance Level
- TXMD $1.24
- EPWK N/A
- Average True Range (ATR)
- TXMD 0.08
- EPWK 0.00
- MACD
- TXMD 0.00
- EPWK 0.00
- Stochastic Oscillator
- TXMD 59.62
- EPWK 0.00
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About EPWK EPWK Holdings Ltd. Class A Ordinary Shares
EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.